{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:44:48Z","timestamp":1790855088854,"version":"4.1.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) have emerged as a promising cell-free therapeutic strategy for acute respiratory distress syndrome (ARDS), a condition with limited effective treatment options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review synthesizes findings from 51 in vivo preclinical studies investigating the efficacy, delivery methods, mechanisms of action, and optimization strategies of MSC-EV interventions in experimental ARDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across diverse models and etiologies, MSC-EVs consistently attenuated inflammation, improved gas exchange, and enhanced survival. Mechanistically, these benefits were largely attributed to microRNA-mediated immunomodulation, including promotion of anti-inflammatory macrophage phenotypes and improved bacterial clearance. Factors influencing therapeutic efficacy included the MSC source, EV preconditioning, timing of administration, and route of delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Despite these encouraging findings, critical methodological heterogeneity limits reproducibility and translational potential. This heterogeneity is particularly evident in dose metrics (e.g., particle number versus protein content), EV quantification methods (e.g., flow cytometry versus nanoparticle tracking analysis), and timing of outcome assessment. This review underscores the growing body of preclinical evidence supporting MSC-EVs in ARDS and identifies key knowledge gaps such as optimal dosing, safety profiling, and scalable manufacturing that must be addressed to enable clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1665948","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:56:35Z","timestamp":1761720995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Extracellular vesicles from mesenchymal stromal cells as a promising therapy for ARDS: a systematic review of preclinical studies"],"prefix":"10.3389","volume":"12","author":[{"given":"Samuel C. F.","family":"Couto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miqu\u00e9ias","family":"Lopes-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia C.","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia R. M.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13054-025-05291-0","article-title":"A narrative review on the future of ARDS: evolving definitions, pathophysiology, and tailored management","volume":"29","author":"Al-Husinat","year":"2025","journal-title":"Crit Care."},{"key":"B2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"J Am Med Assoc."},{"key":"B3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bpa.2020.09.001","article-title":"Mechanical ventilation in neurocritical care setting: a clinical approach","volume":"35","author":"Battaglini","year":"2021","journal-title":"Best Pract Res Clin Anaesthesiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/13543784.2023.2288080","article-title":"Anti-inflammatory therapies for acute respiratory distress syndrome","volume":"32","author":"Battaglini","year":"2023","journal-title":"Expert Opin Investig Drugs."},{"key":"B5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10565-019-09493-5","article-title":"Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome","volume":"36","author":"Lopes-Pacheco","year":"2020","journal-title":"Cell Biol Toxicol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1186\/s13287-023-03402-8","article-title":"Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial","volume":"14","author":"Zarrabi","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/sctm.20-0472","article-title":"Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1\/2a, randomized controlled trial","volume":"10","author":"Lanzoni","year":"2021","journal-title":"Stem Cells Transl Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"709225","DOI":"10.3389\/fcell.2021.709225","article-title":"Persistency of mesenchymal stromal\/stem cells in lungs","volume":"9","author":"Ferrini","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jcyt.2024.04.074","article-title":"GMP-compliant extracellular vesicles derived from umbilical cord mesenchymal stromal cells: manufacturing and pre-clinical evaluation in ARDS treatment","volume":"26","author":"Costa-Ferro","year":"2024","journal-title":"Cytotherapy."},{"key":"B12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/14712598.2020.1689954","article-title":"Therapeutic potential of mesenchymal stem\/stromal cell-derived secretome and vesicles for lung injury and disease","volume":"20","author":"Liu","year":"2020","journal-title":"Exp Opin Biol Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"600711","DOI":"10.3389\/fcell.2021.600711","article-title":"Mesenchymal stromal cell-derived extracellular vesicles in lung diseases: current status and perspectives","volume":"9","author":"Abreu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"30519","DOI":"10.1002\/jcb.30519","article-title":"Umbilical cord MSC-derived exosomes improve alveolar macrophage function and reduce LPS-induced acute lung injury","volume":"125","author":"Cui","year":"2024","journal-title":"J Cell Biochem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/cells13020122","article-title":"The MSC-EV-microRNAome: a perspective on therapeutic mechanisms of action in sepsis and ARDS","volume":"13","author":"dos Santos","year":"2024","journal-title":"Cells"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12451","DOI":"10.1002\/jev2.12451","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"B18","doi-asserted-by":"publisher","first-page":"bmj","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jcyt.2023.04.005","article-title":"An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization\/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue\u2013derived MSCs for research purposes","volume":"25","author":"Viswanathan","year":"2023","journal-title":"Cytotherapy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1164\/rccm.201410-1765OC","article-title":"Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice","volume":"192","author":"Monsel","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12951-023-02038-3","article-title":"Human umbilical cord mesenchymal stromal cell small extracellular vesicle transfer of microRNA-223-3p to lung epithelial cells attenuates inflammation in acute lung injury in mice","volume":"21","author":"Chen","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13287-023-03385-6","article-title":"Nebulised mesenchymal stem cell derived extracellular vesicles ameliorate E. coli induced pneumonia in a rodent model","volume":"14","author":"Gonzalez","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12931-024-02908-w","article-title":"Therapeutic efficacy of thrombin-preconditioned mesenchymal stromal cell-derived extracellular vesicles on Escherichia coli-induced acute lung injury in mice","volume":"25","author":"Bang","year":"2024","journal-title":"Respir Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1002\/ctm2.287","article-title":"Role of miR-466 in mesenchymal stromal cell derived extracellular vesicles treating inoculation pneumonia caused by multidrug-resistant Pseudomonas aeruginosa","volume":"11","author":"Shi","year":"2021","journal-title":"Clin Transl Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13062-024-00586-8","article-title":"Enhanced itaconic acid secretion from macrophages mediates the protection of mesenchymal stem cell-derived exosomes on lipopolysaccharide-induced acute lung injury mice","volume":"19","author":"Wen","year":"2024","journal-title":"Biol Direct"},{"key":"B26","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1021\/acsbiomaterials.3c00614","article-title":"Extracellular vesicles derived from human adipose-derived mesenchymal stem cells alleviate sepsis-induced acute lung injury through a microRNA-150-5p-dependent mechanism","volume":"10","author":"Zhao","year":"2024","journal-title":"ACS Biomater Sci Eng."},{"key":"B27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13062-022-00351-9","article-title":"Small extracellular vesicles derived from Nrf2-overexpressing human amniotic mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting NLRP3","volume":"17","author":"Xu","year":"2022","journal-title":"Biol Direct"},{"key":"B28","doi-asserted-by":"publisher","first-page":"110693","DOI":"10.1016\/j.intimp.2023.110693","article-title":"HSF1 enhances the attenuation of exosomes from mesenchymal stem cells to hemorrhagic shock induced lung injury by altering the protein profile of exosomes","volume":"123","author":"Jia","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13287-021-02143-w","article-title":"MSC-NTF (NurOwn\u00ae) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model","volume":"12","author":"Kaspi","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"811","DOI":"10.4252\/wjsc.v16.i8.811","article-title":"Microvesicles derived from mesenchymal stem cells inhibit acute respiratory distress syndrome-related pulmonary fibrosis in mouse partly through hepatocyte growth factor","volume":"16","author":"Chen","year":"2024","journal-title":"World J Stem Cells."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1097\/ALN.0000000000002655","article-title":"Extracellular vesicles from interferon-\u03b3-primed human umbilical cord mesenchymal stromal cells reduce Escherichia coli\u2013induced acute lung injury in rats","volume":"130","author":"Varkouhi","year":"2019","journal-title":"Anesthesiology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13287-024-03708-1","article-title":"Manufacturing, quality control, and GLP-grade preclinical study of nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles","volume":"15","author":"Wang","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"232729","DOI":"10.3390\/cells12232729","article-title":"Human placental mesenchymal stem cells and derived extracellular vesicles ameliorate lung injury in acute respiratory distress syndrome murine model","volume":"12","author":"Valiukevi\u010dius","year":"2023","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7837837","DOI":"10.1155\/2022\/7837837","article-title":"Differential lung protective capacity of exosomes derived from human adipose tissue, bone marrow, and umbilical cord mesenchymal stem cells in sepsis-induced acute lung injury","volume":"2022","author":"Deng","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.18632\/aging.102314","article-title":"Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury","volume":"11","author":"Huang","year":"2019","journal-title":"Aging."},{"key":"B36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13287-023-03375-8","article-title":"MiR-146a-5p delivered by hucMSC extracellular vesicles modulates the inflammatory response to sulfur mustard-induced acute lung injury","volume":"14","author":"Pei","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/thoraxjnl-2021-218194","article-title":"Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis","volume":"78","author":"Su","year":"2023","journal-title":"Thorax."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1136964","DOI":"10.3389\/fimmu.2023.1136964","article-title":"Mesenchymal stem cell-derived exosomes for treatment of sepsis","volume":"14","author":"Homma","year":"2023","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1021\/acsbiomaterials.3c01173","article-title":"PD-L1-expressing extracellular vesicles for the treatment of pneumonia","volume":"9","author":"Wu","year":"2023","journal-title":"ACS Biomater Sci Eng."},{"key":"B40","doi-asserted-by":"publisher","first-page":"8987049","DOI":"10.1155\/2023\/8987049","article-title":"Small extracellular vesicles secreted by iPSC-derived MSCs ameliorate pulmonary inflammation and lung injury induced by sepsis through delivery of miR-125b-5p","volume":"2023","author":"Peng","year":"2023","journal-title":"J Immunol Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"E599","DOI":"10.1097\/CCM.0000000000004315","article-title":"Mesenchymal stem cell-derived extracellular vesicles alleviate acute lung injury via transfer of miR-27a-3p*","volume":"48","author":"Wang","year":"2020","journal-title":"Crit Care Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"17439","DOI":"10.1021\/acsnano.1c03231","article-title":"Cell-matrix interactions regulate functional extracellular vesicle secretion from mesenchymal stromal cells","volume":"15","author":"Lenzini","year":"2021","journal-title":"ACS Nano."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e02978","DOI":"10.1183\/13993003.02978-2020","article-title":"Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS","volume":"58","author":"Silva","year":"2021","journal-title":"Eur Respir J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/stem.2619","article-title":"Mesenchymal stem cell microvesicles attenuate acute lung injury in mice partly mediated by Ang-1 mRNA","volume":"35","author":"Tang","year":"2017","journal-title":"Stem Cells."},{"key":"B45","doi-asserted-by":"publisher","first-page":"E880","DOI":"10.1097\/CCM.0000000000005056","article-title":"Mitochondria-rich fraction isolated from mesenchymal stromal cells reduces lung and distal organ injury in experimental sepsis*","volume":"49","author":"De Carvalho","year":"2021","journal-title":"Crit Care Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e0259732","DOI":"10.1371\/journal.pone.0259732","article-title":"Mesenchymal stromal cell-derived extracellular vesicles reduce lung inflammation and damage in nonclinical acute lung injury: Implications for COVID-19","volume":"16","author":"Cloer","year":"2021","journal-title":"PLoS ONE"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-024-10784-6","article-title":"Exosomal drug delivery systems: a novel therapy targeting PD-1 in septic-ALI","author":"Huang","year":"2024","journal-title":"Stem Cell Rev Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJN.S485012","article-title":"Apoptotic vesicles attenuate acute lung injury via CD73-mediated inhibition of platelet activation and netosis","volume":"20","author":"Tan","year":"2025","journal-title":"Int J Nanomedicine."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1162615","DOI":"10.3389\/fmed.2023.1162615","article-title":"Nebulized mesenchymal stem cell derived conditioned medium ameliorates Escherichia coli induced pneumonia in a rat model","volume":"10","author":"Gonz\u00e1lez","year":"2023","journal-title":"Front Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.4049\/jimmunol.1801534","article-title":"Mesenchymal stem cell\u2013derived extracellular vesicles decrease lung injury in mice","volume":"203","author":"Hao","year":"2019","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13287-018-0774-8","article-title":"Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model","volume":"9","author":"Khatri","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"B52","doi-asserted-by":"publisher","first-page":"12495","DOI":"10.1002\/jev2.12495","article-title":"Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in SARS-CoV-2 and H1N1 influenza-induced acute lung injury","volume":"13","author":"Lee","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/DDDT.S344309","article-title":"Wnt\/\u03b2-catenin participates in the repair of acute respiratory distress syndrome-associated early pulmonary fibrosis via mesenchymal stem cell microvesicles","volume":"16","author":"Zhang","year":"2022","journal-title":"Drug Des Devel Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"152627","DOI":"10.1016\/j.tox.2020.152627","article-title":"Adipose mesenchymal stem cell-derived antioxidative extracellular vesicles exhibit anti-oxidative stress and immunomodulatory effects under PM2","volume":"447","author":"Gao","year":"2021","journal-title":"Toxicology"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1665948\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:56:36Z","timestamp":1761720996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1665948\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":54,"alternative-id":["10.3389\/fmed.2025.1665948"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1665948","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1665948"}}